Navigation Links
New findings by St. Michael's researchers about the way cells work
Date:1/10/2012

New findings by St. Michael's researchers about the way cells work could lead to a test and therapy for kidney failure caused by E. coli

TORONTO, Ont., Jan. 10, 2012Ever since the water supply in Walkerton, Ont., was contaminated by E. coli in 2000, Dr. Philip Marsden has been trying to figure out just how a toxin released by that particular strain of the bacteria causes kidney damage in children.

Now Dr. Marsden and his team based at St. Michael's Hospital and the University of Toronto, led by graduate student Tania Petruzziello-Pellegrini, together with an international team of collaborators, have made new discoveries about the basic workings of endothelial cells that could lead to a diagnostic test for the serious kidney disease known as hemolytic uremic syndrome (HUS) and a possible treatment.

Endothelial cells line the inside of blood vessels and are the cells most severely affected in HUS, one of the most common causes of sudden onset kidney failure in children.

His work took a sudden twist in May 2011, when an E. coli outbreak swept northern Germany and researchers discovered that a different strain of the bacteria was producing the identical toxin. This time the HUS mainly affected adults, especially women, and was associated with severe kidney failure and strokes.

Dr. Marsden's team extracted endothelial cells from healthy people and exposed them to the toxin in a culture dish. They discovered a biological pathway never before known to have played a role in the development of HUS.

Specifically, they found that the toxin can increase the level of a chemokine, namely SDF-1, and its receptor, CXCR4. Chemokines are small secreted proteins that stimulate cells to move or migrate. CXCR4 was already known to stimulate the release and migration of the precursors of white blood cells from bone marrow, to change how blood vessels grow and to help the AIDS virus enter cells.

Dr. Marsden has found that too much communication between SDF-1 and CXCR4 molecules can also impact the development of HUS in animals and humans. His team made two important discoveries, published in The Journal of Clinical Investigation:

  • injecting the drug plerixafor/AMD3100 (sold under the brand name Mozobil) into mice exposed to the E. coli toxin changed their survival rate and helped improve the HUS, suggesting future therapy options for humans. The drug blocks SDF-1 action on cells that express CXCR4. The drug is used to mobilize precursor stem cells from the bone marrow in some bone marrow transplant recipients during the treatment of non-Hodgkin lymphoma and multiple myeloma.
  • blood tests taken from children with E. coli showed that those who went on to develop HUS had higher levels of the protein SDF-1as much as four times higher than other children with E. coli who did not go on to develop HUS. This suggests that a blood test could be used to predict who is most likely to develop the potentially fatal HUS, meaning they could be monitored more closely.

Dr. Marsden, who is a nephrologist, said a safe water supply and clean food supply chain is the most important step in preventing HUS caused by E. coli.

"If we can measure SDF-1 levels in real time during an E. coli outbreak and confirm these findings, then we have a strong case for a trial of plerixafor/AMD3100 in patients with toxin-producing E. coli to see if it prevents or improves cases of HUS," he said.


'/>"/>

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital
Source:Eurekalert

Related biology news :

1. September 2007 Sumatran earthquakes research findings
2. Findings uncover new details about mysterious virus
3. Nearly a century later, new findings support Warburg theory of cancer
4. New research findings may enable earlier diagnosis of uterine cancer
5. Therapeutic cloning gets a boost with new research findings
6. International climate change researchers meet, review latest findings
7. Findings show insulin -- not genes -- linked to obesity
8. FANTOM findings boost for biologists
9. New findings in taste and smell
10. SRI International announces findings from new upper atmospheric radar system for scientific research
11. USC researchers present diabetes findings at American Diabetes Association Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2016)... "The biometric system market ... The biometric system market is in the growth stage ... future. The biometric system market is expected to be ... CAGR of 16.79% between 2016 and 2022. Government initiative ... in smartphones, rising use of biometric technology in financial ...
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, a ... for public safety, investigation, corrections and monitoring, announced today ... competitor, ICSolutions, to have an independent technology judge determine ... most modern high tech/sophisticated telephone calling platform, and the ... that they do most of what we do – ...
(Date:11/15/2016)... DUBLIN , Nov 15, 2016 Research ... - Global Forecast to 2021" report to their offering. ... ... reach USD 16.18 Billion by 2021 from USD 6.21 Billion in ... Growth of the bioinformatics market is driven by ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... December 01, 2016 , ... ... (CSS) and the popularity of US Single Day Events (SDE) to organize a ... Summer 2018, in Raleigh, NC. Topics of the pharmaceutical and life sciences industry ...
(Date:12/2/2016)... ... December 01, 2016 , ... Orthogonal, a Chicago-based ... recent FDA Class II 510(k) clearance for their flagship medical device, SimplECG. , ... cardiac monitoring devices that rely on cloth-based nanosensors. While other companies have attempted ...
(Date:12/2/2016)... 1, 2016   SurePure, Inc. (OTCQB: SURP) ... the Company has concluded an agreement with Tamarack Biotics ... 90-day period to acquire units of the Company,s patented ... 3.7 million.  Concurrently with the option, ... which Tamarack will seek regulatory approvals in ...
(Date:11/30/2016)... ... 2016 , ... BEI Kimco, a brand of Sensata Technologies, ... that ensures high alignment accuracy by preventing unwanted shaft rotation. The new VCA ... precision is required, such as in medical equipment, laboratory instrumentation, clean rooms, low-outgassing ...
Breaking Biology Technology: